1,274 results on '"Lee, Jeong Eon"'
Search Results
2. Social support during re-entry period and long-term quality of life in breast cancer survivors: a 10-year longitudinal cohort study
3. Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile
4. Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants
5. Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations
6. Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients
7. Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes
8. Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA
9. Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
10. Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)
11. Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?
12. Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer
13. Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis
14. Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
15. Migratory Tumor Cells Cooperate with Cancer Associated Fibroblasts in Hormone Receptor-Positive and HER2-Negative Breast Cancer
16. Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
17. The Effects of National Insurance Coverage Expansion and Genetic Counseling’s Role on BRCA1/2 Mutation Tests in Breast Cancer Patients
18. A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer
19. Celastrol attenuates amphiregulin expression by inhibiting MAPK signaling pathway in triple-negative breast cancer cells
20. Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
21. Histologic analysis according to HER2 gene status in HER2 2 + invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
22. Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching
23. Comparative analysis of mesenchymal stem cells cultivated in serum free media
24. Efficient separation of large particles and giant cancer cells using an isosceles trapezoidal spiral microchannel.
25. Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
26. Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI‐related distress scale (MRI‐DS).
27. Effect of mind and body education on quality of life among young breast cancer patients: a randomized controlled trial
28. Author Response: Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues
29. Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues
30. Effects of Perceived Organizational Justice on Organizational Citizenship Behaviors
31. Exploration of Mechanisms of Drug Resistance in a Microfluidic Device and Patient Tissues
32. Author Response: Exploration of Mechanisms of Drug Resistance in a Microfluidic Device and Patient Tissues
33. Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer
34. Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution’s experience in Korea
35. ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?
36. Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
37. ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction—International Multicenter Pooled Data Analysis
38. Generation of brain organoids from mouse ESCs via teratoma formation
39. Prognostic value of structural variants in early breast cancer patients.
40. The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer.
41. Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding.
42. The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis
43. The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
44. Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer
45. Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer
46. Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
47. Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?
48. The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial
49. Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
50. Author Correction: Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.